Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Marlana Orloff, MD

Associate Professor
Department of Medical Oncology
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States

Disclosures

Marlana Orloff, MD, has the following relevant financial relationships:
Consultant or advisor for: Delcath Systems; IDEAYA Biosciences; TriSalus Life Sciences
Speaker or member of speakers bureau for: Immunocore
Research funding from: Ascentage Pharma Group; Bristol Myers Squibb; IDEAYA Biosciences; Immunocore; Innovent Bio; Iovance Biotherapeutics; Linnaeus; TriSalus Life Sciences

Sophie Piperno-Neumann, MD

Medical Oncologist
Department of Medical Oncology
Institut Curie
Paris, France

Disclosures

Sophie Piperno-Neumann, MD, has the following relevant financial relationships:
Consultant or advisor for: Atlanthera; Immunocore; Pierre Fabre
Speaker or member of speakers bureau for: Immunocore
Research funding from: Merck

Ryan J. Sullivan, MD

Associate Professor, Medicine, Harvard Medical School
Hematology/Oncology, Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosures

Ryan J. Sullivan, MD, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb; Merck; Novartis; Pfizer
Research funding from: Merck

Editor

Keisha Peters, MSc

Keisha Peters, MSc
Medical Education Director, Medscape, LLC

Disclosures

Keisha Peters, MSc, has no relevant financial relationships.

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

CME / ABIM MOC

Advances in the Treatment of Metastatic Uveal Melanoma: Expert Clinical Case Discussions

Authors: Marlana Orloff, MD; Sophie Piperno-Neumann, MD; Ryan J. Sullivan, MD
CME / ABIM MOC Released: 9/30/2022
Valid for credit through: 9/30/2023

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

ABIM Diplomates - maximum of 0.50 ABIM MOC points

You Are Eligible For
- Letter of Completion
- ABIM MOC points

Target Audience and Goal Statement

This activity is intended for ophthalmologists, hematology/oncology specialists, and dermatologists.

The goal of this activity is for the learner to be better able to understand the latest developments in the treatment of uveal melanoma by discussing clinical cases to understand how to apply the latest trial data in clinical practice.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Latest clinical trial data investigating therapies for metastatic uveal melanoma
Have greater competence related to
- Optimal management of patients with metastatic uveal melanoma
- Identifying patients who may benefit from treatment with novel therapies
Demonstrate greater confidence in their ability to
- Understand the implications of the latest clinical trial data

Disclosures

Faculty

Marlana Orloff, MD

Associate Professor
Department of Medical Oncology
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States

Disclosures

Marlana Orloff, MD, has the following relevant financial relationships:
Consultant or advisor for: Delcath Systems; IDEAYA Biosciences; TriSalus Life Sciences
Speaker or member of speakers bureau for: Immunocore
Research funding from: Ascentage Pharma Group; Bristol Myers Squibb; IDEAYA Biosciences; Immunocore; Innovent Bio; Iovance Biotherapeutics; Linnaeus; TriSalus Life Sciences

Sophie Piperno-Neumann, MD

Medical Oncologist
Department of Medical Oncology
Institut Curie
Paris, France

Disclosures

Sophie Piperno-Neumann, MD, has the following relevant financial relationships:
Consultant or advisor for: Atlanthera; Immunocore; Pierre Fabre
Speaker or member of speakers bureau for: Immunocore
Research funding from: Merck

Ryan J. Sullivan, MD

Associate Professor, Medicine, Harvard Medical School
Hematology/Oncology, Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, United States

Disclosures

Ryan J. Sullivan, MD, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb; Merck; Novartis; Pfizer
Research funding from: Merck

Editor

Keisha Peters, MSc

Keisha Peters, MSc
Medical Education Director, Medscape, LLC

Disclosures

Keisha Peters, MSc, has no relevant financial relationships.

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Lisa Simani, APRN, MS, ACNP, has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education

CME / ABIM MOC

Advances in the Treatment of Metastatic Uveal Melanoma: Expert Clinical Case Discussions

Authors: Marlana Orloff, MD; Sophie Piperno-Neumann, MD; Ryan J. Sullivan, MDFaculty and Disclosures

CME / ABIM MOC Released: 9/30/2022

Valid for credit through: 9/30/2023

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 4

CME / ABIM MOC Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Marlana Orloff, MD

Sophie Piperno-Neumann, MD

Ryan J. Sullivan, MD

Editor

Keisha Peters, MSc

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

CME / ABIM MOC

Advances in the Treatment of Metastatic Uveal Melanoma: Expert Clinical Case Discussions

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Marlana Orloff, MD

Sophie Piperno-Neumann, MD

Ryan J. Sullivan, MD

Editor

Keisha Peters, MSc

Compliance Reviewer

Lisa Simani, APRN, MS, ACNP

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Advances in the Treatment of Metastatic Uveal Melanoma: Expert Clinical Case Discussions

Learning Feedback Questions